An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.

by Marci A. Landsmann

Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.

by Sharon Tregaskis

Forward Look

Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.

by Erin O'Donnell

Policy Matters

The AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.

by David A. Tuveson, MD, PhD

Get Involved

A volunteer program brings yoga to cancer patients in the hospital.

by Bradley Jones

Facts and Stats

More people in the U.S. are alive after being diagnosed with cancer than ever before.

by Eric Fitzsimmons

From the Editor-in-Chief

The fast pace of drug discovery should be matched by modernized clinical trials for wider access.

by William G. Nelson, MD, PhD

Policy Matters

The federal agency wants to ban menthol-flavored cigarettes, ban all flavors of cigars, and limit nicotine content.

by Nicholas Warren, PhD

Get Involved

John Hanley's ChemoCookery Twitter account has become a place to share meal ideas and have conversations about cooking, cancer and the crossover between them.

by Bradley Jones

People take cannabis to treat an array of cancer-related symptoms and side effects. Legal prohibitions have stymied attempts at research into cannabis in cancer patients, but doctors are finding creative ways to study its effects.

by Kate Yandell